PAKOLA STEVE

Insider CIK 1700659 · ARPO Chief Medical Officer · RGNX Chief Medical Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
RGNX REGENXBIO Inc.	F Tax w/h	2026-08-01	2026-08-04	7,468	$9.69	$72.4K	205,541	SEC↗
RGNX REGENXBIO Inc.	F Tax w/h	2026-08-01	2026-08-04	7,468	$9.69	$72.4K	205,541	SEC↗
RGNX REGENXBIO Inc.	M Exercise deriv	2026-07-02	2026-07-06	2,161	—	$0	64,812	SEC↗
RGNX REGENXBIO Inc.	M Exercise	2026-07-02	2026-07-06	2,161	$7.86	$17.0K	215,170	SEC↗
RGNX REGENXBIO Inc.	S Sale	2026-07-02	2026-07-06	2,161	$13.64	$29.5K	213,009	SEC↗
RGNX REGENXBIO Inc.	M Exercise deriv	2026-07-01	2026-07-01	36,725	—	$0	66,973	SEC↗
RGNX REGENXBIO Inc.	M Exercise	2026-07-01	2026-07-01	36,725	$7.86	$288.7K	249,734	SEC↗
RGNX REGENXBIO Inc.	S Sale	2026-07-01	2026-07-01	36,725	$12.86	$472.3K	213,009	SEC↗
RGNX REGENXBIO Inc.	S Sale	2026-06-29	2026-07-01	19,608	$11.04	$216.5K	213,009	SEC↗
RGNX REGENXBIO Inc.	S Sale	2026-05-11	2026-05-13	15,309	$11.02	$168.7K	232,617	SEC↗
RGNX REGENXBIO Inc.	S Sale	2026-03-10	2026-03-12	5,124	$10.35	$53.0K	247,926	SEC↗
RGNX REGENXBIO Inc.	F Tax w/h	2026-02-01	2026-02-03	5,267	$11.16	$58.8K	253,050	SEC↗
RGNX REGENXBIO Inc.	A Award deriv	2026-01-06	2026-01-08	35,402	—	$0	35,402	SEC↗
RGNX REGENXBIO Inc.	A Award	2026-01-06	2026-01-08	65,847	—	$0	258,317	SEC↗
RGNX REGENXBIO Inc.	F Tax w/h	2026-01-02	2026-01-06	18,247	$14.40	$262.8K	192,470	SEC↗
RGNX REGENXBIO Inc.	F Tax w/h	2025-02-01	2025-04-04	5,263	$8.07	$42.5K	210,717	SEC↗
RGNX REGENXBIO Inc.	A Award deriv	2025-01-02	2025-01-06	103,698	—	$0	103,698	SEC↗
RGNX REGENXBIO Inc.	A Award	2025-01-02	2025-01-06	64,293	—	$0	215,980	SEC↗
RGNX REGENXBIO Inc.	F Tax w/h	2025-01-02	2025-01-06	13,891	$7.73	$107.4K	151,687	SEC↗
RGNX REGENXBIO Inc.	A Award	2024-08-01	2024-08-05	58,386	—	$0	165,578	SEC↗
RGNX REGENXBIO Inc.	M Exercise deriv	2024-03-05	2024-03-07	12,878	—	$0	31,277	SEC↗
RGNX REGENXBIO Inc.	M Exercise	2024-03-05	2024-03-07	12,878	$22.25	$286.5K	120,070	SEC↗
RGNX REGENXBIO Inc.	S Sale	2024-03-05	2024-03-07	12,878	$28.36	$365.2K	107,192	SEC↗
RGNX REGENXBIO Inc.	S Sale	2024-01-03	2024-01-04	17,237	$17.39	$299.8K	107,192	SEC↗
RGNX REGENXBIO Inc.	A Award deriv	2024-01-02	2024-01-04	50,875	—	$0	50,875	SEC↗
RGNX REGENXBIO Inc.	A Award	2024-01-02	2024-01-04	32,051	—	$0	124,429	SEC↗
RGNX REGENXBIO Inc.	F Tax w/h	2024-01-02	2024-01-04	10,385	$17.95	$186.4K	92,378	SEC↗
RGNX REGENXBIO Inc.	A Award deriv	2023-01-03	2023-01-05	44,155	—	$0	44,155	SEC↗
RGNX REGENXBIO Inc.	S Sale	2023-01-03	2023-01-05	3,138	$22.17	$69.6K	12,175	SEC↗
RGNX REGENXBIO Inc.	A Award	2023-01-03	2023-01-05	90,588	—	$0	102,763	SEC↗
RGNX REGENXBIO Inc.	F Tax w/h	2023-01-03	2023-01-05	1,837	$22.68	$41.7K	15,313	SEC↗
RGNX REGENXBIO Inc.	A Award deriv	2022-01-03	2022-01-04	42,500	—	$0	42,500	SEC↗
RGNX REGENXBIO Inc.	S Sale	2022-01-03	2022-01-04	1,598	$33.75	$53.9K	8,250	SEC↗
RGNX REGENXBIO Inc.	A Award	2022-01-03	2022-01-04	8,900	—	$0	17,150	SEC↗
RGNX REGENXBIO Inc.	F Tax w/h	2022-01-01	2022-01-04	1,152	$32.70	$37.7K	9,848	SEC↗
RGNX REGENXBIO Inc.	A Award deriv	2021-01-04	2021-01-06	49,700	—	$0	49,700	SEC↗
RGNX REGENXBIO Inc.	A Award	2021-01-04	2021-01-06	11,000	—	$0	11,000	SEC↗
RGNX REGENXBIO Inc.	A Award deriv	2020-01-02	2020-01-06	42,600	—	$0	42,600	SEC↗
RGNX REGENXBIO Inc.	A Award deriv	2019-04-17	2019-04-19	95,000	—	$0	95,000	SEC↗
ARPO Aerpio Pharmaceuticals, In	A Award deriv	2019-02-15	2019-02-20	125,000	—	$0	125,000	SEC↗
ARPO Aerpio Pharmaceuticals, In	A Award deriv	2018-04-23	2018-04-25	100,000	—	$0	100,000	SEC↗